Search Nonprofits

The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation and the world through outstanding programs that integrate patient care, research and prevention and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

The Children's Brain Tumor Foundation is a non-profit organization founded in 1988 by dedicated parents, physicians and friends. Our mission is: to improve the treatment, quality of life and the long term outlook for children with brain and spinal cord tumors through research, support, education, and advocacy to families and survivors.

The mission of The Pablove Foundation is to invest in underfunded, cutting-edge pediatric cancer research, inspire cancer families through education, and improve the lives of children living with cancer through the arts. We help kids with cancer live – a love-filled life today, and a cancer-free life tomorrow.

KrabbeConnect's mission is to be the source of comprehensive information and access to resources for patients with Krabbe disease. The foundation will drive state of the art research by bridging the gap between science and patient knowledge. The organization seeks to revolutionize the practice of medicine by identifying, optimizing, and implementing advances in the care and cure of globoid cell leukodystrophy, utilizing a multicenter network.

The mission of the American Brain Tumor Association is to advance the understanding and treatment of brain tumors with the goals of improving, extending and, ultimately, saving the lives of those impacted by a brain tumor diagnosis. We do this through interactions and engagements with brain tumor patients and their families, collaborations with allied groups and organizations, and the funding of brain tumor research.

The mission of the Lung Cancer Research Foundation is to support national research studies and activities focused on developing innovative strategies for better treatments, screening, and prevention of all cancers of the lung. New knowledge gained by funding scientific and clinical research initiatives will lead to more positive outcomes and improved quality of life for all lung cancer patients.

Be The Match Foundation supports the life-saving mission of Be The Match/National Marrow Donor Program, ensuring that patients diagnosed with blood cancers such as leukemia and other diseases get the marrow or cord blood transplant they need for a second chance at life. A transplant offers hope for a cure. We connect patients with their genetically matched donors and provide comprehensive support throughout the transplant journey, from diagnosis through recovery.

The Multiple Myeloma Research Foundation, Inc. mission is to: relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure. To achieve this purpose, four goals are pursued: Funding research in the field of multiple myeloma, building collaborations among researchers and industry, providing disease and treatment related information to patients and family members while advocating for optimal patient care, and raising awareness of multiple myeloma.

Stand Up To Cancer’s (SU2C) mission is to raise funds to accelerate the pace of groundbreaking translational research that can get new therapies to patients quickly and save lives now. SU2C brings together the best and the brightest researchers and mandates collaboration among the cancer community. By galvanizing the entertainment industry, SU2C has set out to generate awareness, educate the public on cancer prevention and help more people diagnosed with cancer become long-term survivors. Stand Up To Cancer is an initiative of the Entertainment Industry Foundation.

Our mission is to provide a community of healing, hope, and light throughout the life-long journey of childhood cancer. We advocate, we educate, we build partnerships, and we foster solidarity for all families experiencing cancer.Candlelighters provides support for families every step of the way from diagnosis through treatment, providing programs such as emergency financial assistance, an annual family camp, family activities, bereavement support, and a meal program that offers comfort and support for families during a difficult journey. Through it all, we never charge families a dime – ever!​

The National Pediatric Cancer Foundation (NPCF) is a nonprofit organization dedicated to funding and developing novel research and clinical trials to find less toxic, more effective treatments for childhood cancer. Our purpose is to reduce the side effects of current treatments, improve survival rates, and ultimately eliminate childhood cancer. NPCF is a nonprofit organization under section 501(c)(3) of the Internal Revenue Code. At the National Pediatric Cancer Foundation, we are aggressively pursuing measurable change in how pediatric cancer research is approached and funded through our collaborative research consortium, the Sunshine Project. The Sunshine Project’s one-of-a-kind research model focuses on translational studies and phase 0, 1, and 2 clinical trials that address a multitude of different pediatric cancers. Our innovative approach capitalizes on the strengths of researchers from various scientific fields throughout the country, streamlining the protocol development process to deliver more personalized medicine to children with cancer. This utilization of scientific and philanthropic partnerships allows us to fast-track potential new therapies with less toxicity into clinical trials. The treatment options currently being discovered bring great promise for children who have not experienced positive results under the standard treatment protocol.

The mission of the NOCC is to save lives through the prevention and cure of ovarian cancer and to improve quality of life for survivors and their caregivers. Nearly 19,800+ women in the United States are diagnosed with ovarian cancer each year, and approximately 12,800+ women die from the disease. Unfortunately, most cases are diagnosed in later stages when the prognosis is poor. However, if diagnosed and treated early when the cancer is confined to the ovary, the five-year survival rate is over 90 percent. This is why it’s imperative that the early signs and symptoms are recognized not only by women, but by their families and the healthcare community.